FDA
approval
· 2018-07-02
FDA Approved: EMTRICITABINE — Original Application (Cipla USA Inc.)
Summary
FDA approved Cipla USA Inc.'s original application for generic emtricitabine, enabling its use in HIV-1 treatment regimens.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for EMTRICITABINE (EMTRICITABINE)